Literature DB >> 12196047

Hospital admissions resulting from preventable adverse drug reactions.

Patrick J McDonnell1, Michael R Jacobs.   

Abstract

BACKGROUND: Adverse drug reactions (ADRs) are a significant cause of hospital admissions. These events can lead to significant morbidity and mortality and financial costs. ADRs that may be preventable might be considered a form of medication error.
OBJECTIVE: To assess the potential preventability of ADRs directly related to a patient's hospital admission.
METHODS: A retrospective chart review of 437 ADRs occurring during an 11-month period was conducted at a university hospital. A subset of these events leading to hospital admissions was identified for further review. Those that resulted in admission were further examined to determine probability of causality, severity, and preventability.
RESULTS: Over 11 months, 158 ADRs were directly related to hospital admission. The relationship of these admissions to drug exposure was determined to be probable or highly probable in 154 (97.4%) of these cases. From this group, 96 (62.3%) of these events were considered potentially preventable, with 23 (24%) considered severe to life-threatening. Characteristics associated with these ADRs included documentation of a toxic drug concentration or abnormal laboratory value (80%), inadequate monitoring of a patient's drug therapy (67%), inappropriate dose (51%), patient noncompliance (33%), drug-drug interaction (26%), contraindication to therapy (3%), and documented allergy (1%). These ADRs resulted in 595 hospital days, with an average length of stay of 6.1 days.
CONCLUSIONS: ADRs leading to hospital admissions are often preventable. Approximately 25% of these events were serious to life-threatening. Most resulted from inadequate monitoring of therapy or inappropriate dosing. Patient noncompliance and drug interactions were also common causes. Multidisciplinary prevention strategies among physicians, pharmacists, other healthcare professionals, and patients focusing on communication and education should be targeted.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12196047     DOI: 10.1345/aph.1A333

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  133 in total

1.  Medication adherence: helping patients take their medicines as directed.

Authors:  Regina M Benjamin
Journal:  Public Health Rep       Date:  2012 Jan-Feb       Impact factor: 2.792

2.  Adverse drug reactions in internal medicine units and associated risk factors.

Authors:  Juan Francisco Sánchez Muñoz-Torrero; Paloma Barquilla; Raul Velasco; Maria del Carmen Fernández Capitan; Nazaret Pacheco; Lucia Vicente; Jose Luis Chicón; Sara Trejo; Jose Zamorano; Alicia Lorenzo Hernandez
Journal:  Eur J Clin Pharmacol       Date:  2010-08-06       Impact factor: 2.953

Review 3.  Optimizing medication adherence: an ongoing opportunity to improve outcomes after kidney transplantation.

Authors:  Mary B Prendergast; Robert S Gaston
Journal:  Clin J Am Soc Nephrol       Date:  2010-05-06       Impact factor: 8.237

4.  Detecting medication errors in the New Zealand pharmacovigilance database: a retrospective analysis.

Authors:  Desireé L Kunac; Michael V Tatley
Journal:  Drug Saf       Date:  2011-01-01       Impact factor: 5.606

5.  Economic and safety benefits of pharmaceutical interventions by community and hospital pharmacists in Japan.

Authors:  Yuichi Tasaka; Daiki Yasunaga; Mamoru Tanaka; Akihiro Tanaka; Takashige Asakawa; Ikuo Horio; Yoshiro Miyauchi; Hiroaki Araki
Journal:  Int J Clin Pharm       Date:  2016-01-08

Review 6.  Potential determinants of drug-drug interaction associated dispensing in community pharmacies.

Authors:  Matthijs L Becker; Marjon Kallewaard; Peter W J Caspers; Tom Schalekamp; Bruno H C Stricker
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

7.  Identification of severe potential drug-drug interactions using an Italian general-practitioner database.

Authors:  L Magro; A Conforti; F Del Zotti; R Leone; M L Iorio; I Meneghelli; D Massignani; E Visonà; U Moretti
Journal:  Eur J Clin Pharmacol       Date:  2007-11-09       Impact factor: 2.953

8.  Characteristics of unplanned hospital admissions due to drug-related problems in cancer patients.

Authors:  Alexandre Chan; Deren Soh; Yu Ko; Yu-Chu Huang; Joen Chiang
Journal:  Support Care Cancer       Date:  2014-02-22       Impact factor: 3.603

9.  Drug-physiology interaction and its influence on the QT prolongation-mechanistic modeling study.

Authors:  Barbara Wiśniowska; Sebastian Polak
Journal:  J Pharmacokinet Pharmacodyn       Date:  2018-03-15       Impact factor: 2.745

10.  Assessing student pharmacists' ability to identify drug-related problems in patients within a patient-centered medical home.

Authors:  Becky L Armor; Christina F Bulkley; Teresa Truong; Sandra M Carter
Journal:  Am J Pharm Educ       Date:  2014-02-12       Impact factor: 2.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.